ahlam1399
09-01-2015, 06:46 PM
Europe gets Amgen cholesterol drug for 50-60 percent of U.S. price
LONDON (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49796f3f/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=MEkybNNJVz4:RFv6vrC2Q5U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=MEkybNNJVz4:RFv6vrC2Q5U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/MEkybNNJVz4
LONDON (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49796f3f/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=MEkybNNJVz4:RFv6vrC2Q5U:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=MEkybNNJVz4:RFv6vrC2Q5U:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=MEkybNNJVz4:RFv6vrC2Q5U:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/MEkybNNJVz4